Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Orchid Pharma Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 210 | 183 | 199 | 221 | 217 | 244 | 223 | 217 | 237 | 173 | 194 | 207 | 238 |
| Expenses + | 170 | 161 | 175 | 185 | 188 | 212 | 192 | 191 | 209 | 159 | 195 | 206 | 211 |
| Operating Profit | 40 | 22 | 23 | 35 | 29 | 32 | 30 | 26 | 28 | 14 | -1 | 2 | 27 |
| OPM % | 19% | 12% | 12% | 16% | 13% | 13% | 14% | 12% | 12% | 8% | -1% | 1% | 11% |
| Other Income + | 34 | 2 | 8 | 8 | 13 | 8 | 8 | 8 | 4 | 11 | 11 | -2 | 8 |
| Interest | 7 | 6 | 4 | 4 | 3 | 4 | 3 | 4 | 4 | 3 | 4 | 3 | 3 |
| Depreciation | 7 | 8 | 8 | 9 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Profit before tax | 59 | 11 | 20 | 30 | 30 | 28 | 26 | 22 | 19 | 14 | -3 | -12 | 23 |
| Tax % | 0% | 0% | 0% | 0% | -10% | -1% | 0% | 0% | -0% | 0% | 0% | 0% | 0% |
| Net Profit + | 59 | 9 | 20 | 29 | 33 | 29 | 27 | 21 | 22 | 15 | -6 | -13 | 24 |
| EPS in Rs | 14.49 | 1.85 | 3.90 | 5.80 | 6.50 | 5.79 | 5.37 | 4.10 | 4.39 | 2.94 | -1.13 | -2.49 | 4.69 |
Financials of Orchid Pharma Ltd
Annual income statement trend
| Mar 2015 18m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,747 | 873 | 797 | 683 | 600 | 484 | 450 | 560 | 666 | 819 | 922 | 811 |
| Expenses + | 1,429 | 703 | 794 | 659 | 612 | 515 | 421 | 505 | 581 | 708 | 804 | 770 |
| Operating Profit | 317 | 171 | 3 | 24 | -12 | -31 | 29 | 55 | 84 | 111 | 118 | 41 |
| OPM % | 18% | 20% | 0% | 4% | -2% | -6% | 7% | 10% | 13% | 14% | 13% | 5% |
| Other Income + | 156 | -28 | -59 | 20 | 218 | 24 | 15 | 67 | 52 | 31 | 27 | 29 |
| Interest | 537 | 294 | 347 | 310 | 7 | 6 | 52 | 33 | 33 | 17 | 15 | 13 |
| Depreciation | 325 | 145 | 141 | 133 | 130 | 118 | 109 | 87 | 55 | 33 | 35 | 35 |
| Profit before tax | -389 | -296 | -544 | -399 | 69 | -131 | -117 | 2 | 48 | 92 | 96 | 21 |
| Tax % | -49% | -6% | -9% | -12% | 0% | 0% | 0% | 0% | 0% | -3% | -0% | -1% |
| Net Profit + | -197 | -279 | -495 | -353 | 69 | -131 | -117 | -2 | 46 | 92 | 100 | 21 |
| EPS in Rs | -23.06 | -31.37 | -55.69 | -39.65 | 7.80 | -32.11 | -28.55 | -0.48 | 11.35 | 18.17 | 19.65 | 4.05 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Orchid Pharma Ltd
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 85 | 89 | 89 | 89 | 89 | 41 | 41 | 41 | 41 | 51 | 51 | 51 |
| Reserves | 244 | -40 | -556 | -881 | -793 | 725 | 612 | 607 | 648 | 1,119 | 1,217 | 1,237 |
| Borrowings + | 3,211 | 3,215 | 3,106 | 3,202 | 3,230 | 566 | 453 | 268 | 331 | 135 | 175 | 363 |
| Other Liabilities + | 521 | 598 | 616 | 715 | 551 | 128 | 132 | 195 | 205 | 249 | 246 | 261 |
| Total Liabilities | 4,061 | 3,862 | 3,256 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | 1,554 | 1,688 | 1,911 |
| Fixed Assets + | 1,795 | 1,637 | 1,497 | 1,386 | 1,256 | 858 | 670 | 584 | 573 | 620 | 633 | 692 |
| CWIP | 282 | 280 | 288 | 272 | 278 | 26 | 7 | 10 | 46 | 31 | 81 | 341 |
| Investments | 1 | 1 | 1 | 1 | 0 | 0 | 15 | 45 | 44 | 46 | 50 | 53 |
| Other Assets + | 1,984 | 1,944 | 1,470 | 1,467 | 1,542 | 576 | 544 | 472 | 561 | 857 | 925 | 826 |
| Total Assets | 4,061 | 3,862 | 3,256 | 3,125 | 3,077 | 1,460 | 1,237 | 1,111 | 1,225 | 1,554 | 1,688 | 1,911 |
Financials of Orchid Pharma Ltd
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -369 | 212 | 401 | 9 | 12 | 81 | 24 | 92 | 18 | 126 | 19 | 101 |
| Cash from Investing Activity + | 1,334 | -1 | -176 | -28 | 45 | 167 | 67 | 113 | -31 | -312 | -27 | -285 |
| Cash from Financing Activity + | -597 | -286 | -465 | 33 | -0 | -250 | -165 | -217 | 31 | 167 | 25 | 170 |
| Net Cash Flow | 367 | -76 | -240 | 15 | 57 | -2 | -74 | -11 | 18 | -19 | 18 | -14 |
| Free Cash Flow | 965 | 211 | 392 | 3 | 5 | 77 | 23 | 238 | -8 | 61 | -131 | -273 |
| CFO/OP | -102% | 124% | 13,628% | 67% | -138% | -226% | 63% | 173% | 22% | 113% | 17% | 240% |
Financials of Orchid Pharma Ltd
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 130 | 75 | 64 | 73 | 51 | 110 | 111 | 118 | 87 | 96 | 119 |
| Inventory Days | 118 | 220 | 196 | 202 | 214 | 254 | 244 | 201 | 217 | 199 | 219 | 178 |
| Days Payable | 146 | 341 | 402 | 374 | 381 | 182 | 176 | 195 | 165 | 173 | 149 | 160 |
| Cash Conversion Cycle | 26 | 9 | -130 | -108 | -94 | 123 | 179 | 117 | 170 | 113 | 166 | 137 |
| Working Capital Days | -49 | -168 | -500 | -876 | -1,158 | 166 | 302 | 97 | 54 | 118 | 135 | 145 |
| ROCE % | 1% | 1% | -4% | -4% | -5% | -6% | -5% | -2% | 5% | 9% | 8% | 3% |